Clinical Whole Genome Sequencing, The Final Frontier
Tom Berkovits,
Director Market Development, Clinical Genomics, Asia Pacific,
Illumina
Unprecedented advances in genome sequencing technology are significantly
changing scientific research, drug development, and clinical care. Just
over a decade after the first human genome was sequenced, an entire
human genome can now be sequenced in a few days. Coupled with a dramatic
decline in sequencing cost, the technology has moved from the cutting
edge of science to a transformative technology, promising to benefit
virtually every area of human health. Genome sequencing offers
significant advances in our understanding of disease, leading to a new
era of precision medicine in which health care can be tailored to the
molecular makeup of an individual. Illumina’s mission is to improve
human health by unlocking the power of the genome. The introduction of
cWGS is enabling this mission to become a reality, using the latest NGS
technology to increase diagnostic yields, shorten time to definitive
diagnoses and simplify test selection.
|
|